THERAPEUTIC GAIN OF CONTINUED, LONG-TERM INFLIXIMAB THERAPY IN CROHN'S DISEASE PATIENTS WITH RESPONSE BUT NON-REMISSION AFTER ONE YEAR OF INFLIXIMAB THERAPY

被引:0
|
作者
Buhl, Sine
Borghede, Marta K.
Brynskov, Jorn
Steenholdt, Casper
Rasmussen, Maria
Ainsworth, Mark A.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Su1894
引用
收藏
页码:S623 / S624
页数:2
相关论文
共 50 条
  • [21] Long-term outcome of Crohn's disease patients treated with infliximab
    Chen, B. L.
    Lv, S. C.
    Feng, T.
    Li, M. Y.
    Rao, P. S.
    Zeng, Z. R.
    Hu, P. J.
    Chen, M. H.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S245 - S245
  • [22] Mucosal Healing Predicts Long-term Outcome of Maintenance Therapy with Infliximab in Crohn's Disease
    Schnitzler, Fabian
    Fidder, Herma
    Ferrante, Marc
    Noman, Maja
    Arijs, Ingrid
    Van Assche, Gert
    Hoffman, Ilse
    Van Steen, Kristel
    Vermeire, Severine
    Rutgeerts, Paul
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (09) : 1295 - 1301
  • [23] Combination Therapy with Infliximab and Thiopurine Compared to Infliximab Monotherapy in Maintaining Remission of Postoperative Crohn's Disease
    Sakuraba, Atsushi
    Okamoto, Susumu
    Matsuoka, Katsuyoshi
    Sato, Toshiro
    Naganuma, Makoto
    Hisamatsu, Tadakazu
    Iwao, Yasushi
    Ogata, Haruhiko
    Kanai, Takanori
    Hibi, Toshifumi
    DIGESTION, 2015, 91 (03) : 233 - 238
  • [24] Factors predicting the therapeutic response to infliximab during maintenance therapy in Japanese patients with Crohn's disease
    Matsuoka, Katsuyoshi
    Hamada, Shunsuke
    Shimizu, Mikiko
    Nanki, Kosaku
    Mizuno, Shinta
    Kiyohara, Hiroki
    Arai, Mari
    Sugimoto, Shinya
    Iwao, Yasushi
    Ogata, Haruhiko
    Hisamatsu, Tadakazu
    Naganuma, Makoto
    Kanai, Takanori
    Mochizuki, Mayumi
    Hashiguchi, Masayuki
    PLOS ONE, 2018, 13 (10):
  • [25] Colon Cancer After Infliximab Therapy for Crohn’s Disease
    Frederico Ferreira
    Susana Lopes
    Guilherme Macedo
    BioDrugs, 2010, 24 : 18 - 21
  • [26] Colon Cancer After Infliximab Therapy for Crohn's Disease
    Ferreira, Frederico
    Lopes, Susana
    Macedo, Guilherme
    BIODRUGS, 2010, 24 : 18 - 21
  • [27] Interstitial pneumonitis after infliximab therapy for Crohn's disease
    Weatherhead, M
    Masson, S
    Bourke, SJ
    Gunn, MC
    Burns, GP
    INFLAMMATORY BOWEL DISEASES, 2006, 12 (05) : 427 - 428
  • [28] Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn's disease under infliximab therapy
    Cao, Wan-Ting
    Huang, Rong
    Liu, Shan
    Fan, Yi-Hong
    Xu, Mao-Sheng
    Xu, Yi
    Ni, Hui
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (23) : 2582 - 2596
  • [29] Understanding Infliximab in Crohn's Disease: The Long-Term Outcomes
    Turner, Dan
    Lev-Tzion, Raffi
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (03) : 604 - 607
  • [30] Understanding Infliximab in Crohn’s Disease: The Long-Term Outcomes
    Dan Turner
    Raffi Lev-Tzion
    Digestive Diseases and Sciences, 2013, 58 : 604 - 607